Sign in Subscribe
Class action lawsuits

Pomerantz LLP Investigates Claims of Securities Fraud Against Neogen Corporation

Strategic Insights

— 1 min read

Pomerantz LLP is leading an investigation into potential securities fraud allegations against Neogen Corporation, following the company's disclosure of its fourth quarter fiscal 2025 financial results. On June 4, 2025, Neogen announced that its EBITDA margin would likely be around 17%, a significant decline from the previous quarter's 22%. The company attributed the decrease to elevated inventory write-offs, prompting a stock price drop of $1.04 per share, or 17.3%, to close at $4.96 per share.

Key Takeaways:

  • Pomerantz LLP is investigating claims of securities fraud against Neogen Corporation on behalf of investors.
  • Neogen disclosed that its fourth quarter fiscal 2025 financial results would be "materially approximate" to its guided range, but EBITDA margin would likely be around 17%.
  • The company attributed the decline in EBITDA margin to elevated inventory write-offs.
  • Neogen's stock price fell $1.04 per share, or 17.3%, to close at $4.96 per share on June 4, 2025.
  • Pomerantz LLP has a long history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Statistics:

  • Neogen's stock price dropped by $1.04 per share, or 17.3%, to close at $4.96 per share on June 4, 2025.
  • The company's EBITDA margin is expected to be around 17% in the fourth quarter fiscal 2025.
  • Neogen's previous quarter EBITDA margin was 22%.
  • The investigation concerns whether Neogen and certain of its officers and/or directors engaged in securities fraud or other unlawful business practices.

Sources:

  • Pomerantz LLP
  • GlobeNewswire
  • Neogen Corporation's investor relations website
  • The Pomerantz Firm's website (2025-07-28)

Read more